Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
Powell AA, Ireland G, Leeson R, Lacey A, Ford B, Poh J, Ijaz S, Shute J, Cherepanov P, Tedder R, Bottomley C, Dawe F, Mangtani P, Jones P, Nguipdop-Djomo P, Ladhani SN; COVID-19 Schools Infection Survey Group. Powell AA, et al. Among authors: mangtani p. J Infect. 2023 Apr;86(4):361-368. doi: 10.1016/j.jinf.2023.02.016. Epub 2023 Feb 15. J Infect. 2023. PMID: 36803676 Free PMC article.
Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
Neuzil KM, Bresee JS, de la Hoz F, Johansen K, Karron RA, Krishnan A, Madhi SA, Mangtani P, Spiro DJ, Ortiz JR; WHO Preferred Product Characteristics for Next-Generation Influenza Vaccines Advisory Group. Neuzil KM, et al. Among authors: mangtani p. Vaccine. 2017 Oct 13;35(43):5734-5737. doi: 10.1016/j.vaccine.2017.08.088. Epub 2017 Sep 20. Vaccine. 2017. PMID: 28893473 Free article.
Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
Mangtani P, Evans SJW, Lange B, Oberle D, Smith J, Drechsel-Baeuerle U, Keller-Stanislawski B. Mangtani P, et al. Vaccine. 2020 Jan 29;38(5):963-978. doi: 10.1016/j.vaccine.2019.11.070. Epub 2019 Dec 12. Vaccine. 2020. PMID: 31839467
WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.
Stuurman AL, Sharan A, Jahagirdar S, Elango V, Riera-Montes M, Kashyap N, Biccler J, Poluru R, Arora N, Mathai M, Mangtani P, DeVlieger H, Anderson S, Whitaker B, Wong HL, Cutland C, Guillard Maure C; WHO GVS MCC Sites. Stuurman AL, et al. Among authors: mangtani p. Vaccine X. 2021 Nov 3;9:100123. doi: 10.1016/j.jvacx.2021.100123. eCollection 2021 Dec. Vaccine X. 2021. PMID: 34825164 Free PMC article.
126 results